| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 119,592 | 115,327 | 100,595 | 141,523 | | Cost of Revenue | 71,270 | 68,924 | 59,888 | 83,717 | | | Gross Profit | 48,322 | 46,403 | 40,707 | 57,806 | | | Operating Expenses | | Research Development | 19,975 | 18,995 | 17,286 | 15,940 | | Selling General and Administrative | 13,764 | 12,944 | 12,786 | 13,714 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 14,583 | 14,464 | 10,635 | 28,152 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (112) | 612 | (2,356) | (1,935) | | Earnings Before Interest And Taxes | 14,471 | 15,076 | 8,279 | 26,217 | | Interest Expense | 1,423 | 234 | 234 | 321 | | Income Before Tax | 13,048 | 14,842 | 8,045 | 25,896 | | Income Tax Expense | 3,244 | 1,760 | 1,959 | 4,699 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 9,804 | 13,082 | 6,086 | 21,197 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 9,804 | 13,082 | 6,086 | 21,197 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $9,804 | $13,082 | $6,086 | $21,197 |
|
0.12% Nasdaq 
0.31%
Income Statement
